THRM Gentherm Incorporated

Gentherm Reports Grant of Previously Announced CEO and CFO Inducement Awards Under Nasdaq Listing Rule

Gentherm Reports Grant of Previously Announced CEO and CFO Inducement Awards Under Nasdaq Listing Rule

William Presley and Jonathan Douyard received inducement RSU grants in accordance with their offer letters and pursuant to Nasdaq Rule 5635(c)(4)

NOVI, Mich., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that the Compensation and Talent Committee (the “Committee”) of the Board of Directors has granted inducement equity awards to newly appointed William Presley, President and Chief Executive Officer, and Jonathan Douyard, Executive Vice President, Chief Financial Officer and Treasurer, each effective February 24, 2025. The awards were made in accordance with the previously announced offer letters entered into between Gentherm and each of Mr. Presley and Mr. Douyard, and were material inducements to the new employees entering into employment with Gentherm.

Mr. Presley and Mr. Douyard were granted awards consisting of 123,135 and 52,398 restricted stock units (“RSUs”), respectively, that vest in equal portions annually on each of the first three anniversaries of the grant date, subject to their respective continued employment with Gentherm. The RSUs generally have terms and conditions consistent with those set forth in the Gentherm Incorporated 2023 Equity Incentive Plan, but were granted outside of such plan. The grants were approved by the Committee in reliance on the employment inducement exemption under Rule 5635(c)(4) of the Nasdaq Marketplace Rules, which requires this public announcement.

Investor Contact 

Gregory Blanchette



248.308.1702 

Media Contact 

Melissa Fischer 



248.289.9702 

About Gentherm

Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include variable temperature Climate Control Seats®, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, Morocco, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to . 



EN
24/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Gentherm Incorporated

 PRESS RELEASE

Gentherm Announces Participation in Upcoming Roth Conference

Gentherm Announces Participation in Upcoming Roth Conference NOVI, Mich., March 11, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the 38th Annual ROTH Conference in Dana Point, California. Bill Presley, President and CEO, and Jon Douyard, Executive Vice President, Chief Financial Officer and Treasurer, will be hosting investors on Monday, March 23, 2026 and Tuesday, March 24, 2026. Please note that event participation and specific dates ar...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Gentherm Reports 2025 Fourth Quarter and Full Year Results

Gentherm Reports 2025 Fourth Quarter and Full Year Results Achieved Record Annual Revenue of $1.5 Billion  Increased Full Year Operating Cash Flow 7% Year-over-Year; Reduced Net Leverage to 0.2x Establishes 2026 Guidance; Provides Preliminary Revenue Outlook of ~$1.7B for 2027 NOVI, Mich., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the fourth quarter and full year ended December 31, 2025. “We made significant progress on our long-...

 PRESS RELEASE

Gentherm Announces Date for 2025 Fourth Quarter and Year-End Results N...

Gentherm Announces Date for 2025 Fourth Quarter and Year-End Results News Release and Conference Call NOVI, Mich., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the fourth quarter and year-end 2025 on Thursday, February 19, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13758613 Webca...

 PRESS RELEASE

Gentherm Announces FDA 510(k) Submission for Innovative Technology Exp...

Gentherm Announces FDA 510(k) Submission for Innovative Technology Expected to Promote Safer Surgeries and Better Patient Outcomes Market launch for its first of a kind integrated patient warming and securement system planned for third quarter of this year NOVI, Mich., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM) a global market leader of innovative thermal management and pneumatic comfort technologies, today announced it submitted a 510(k) Class II premarket notification to the U.S. Food and Drug Administration (FDA) for ThermAffyx™ Patient Safety System, an integrated pat...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch